These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

276 related items for PubMed ID: 17515941

  • 1. Management of scleroderma in a New Zealand tertiary rheumatology centre: emphasis on pulmonary complications.
    Ng K, Gow P.
    N Z Med J; 2007 May 18; 120(1254):U2537. PubMed ID: 17515941
    [Abstract] [Full Text] [Related]

  • 2. Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological status.
    Simeón-Aznar CP, Fonollosa-Plá V, Tolosa-Vilella C, Espinosa-Garriga G, Ramos-Casals M, Campillo-Grau M, García-Hernández FJ, Castillo-Palma MJ, Sánchez-Román J, Callejas-Rubio JL, Ortego-Centeno N, Egurbide-Arberas MV, Trapiellla-Martínez L, Gallego-Villalobos M, Sáez-Comet L, Velilla-Marco J, Camps-García MT, de Ramón-Garrido E, Esteban Marcos EM, Pallarés-Ferreres L, Hidalgo-Tenorio C, Sabio-Sánchez JM, Gómez-de la Torre R, Salvador-Cervello G, Rios-Blanco JJ, Gil-Aguado A, Vilardell-Tarrés M.
    Semin Arthritis Rheum; 2012 Jun 18; 41(6):789-800. PubMed ID: 22169458
    [Abstract] [Full Text] [Related]

  • 3. Screening for pulmonary arterial hypertension in patients with scleroderma--a New Zealand perspective.
    Ghosh SK, Corkill MM, Hart HH, Ng KP.
    N Z Med J; 2014 Aug 15; 127(1400):30-8. PubMed ID: 25145365
    [Abstract] [Full Text] [Related]

  • 4. Determinants of morbidity and mortality of systemic sclerosis in Canada.
    Al-Dhaher FF, Pope JE, Ouimet JM.
    Semin Arthritis Rheum; 2010 Feb 15; 39(4):269-77. PubMed ID: 18706680
    [Abstract] [Full Text] [Related]

  • 5. Improved survival in systemic sclerosis is associated with better ascertainment of internal organ disease: a retrospective cohort study.
    Nihtyanova SI, Tang EC, Coghlan JG, Wells AU, Black CM, Denton CP.
    QJM; 2010 Feb 15; 103(2):109-15. PubMed ID: 19966313
    [Abstract] [Full Text] [Related]

  • 6. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G, De Nardo D, Capria A, Manenti G, Fabiano S, Borzi M, De Sanctis G, Konda D, Sperandio M, Schillaci O, Masala S, Simonetti G, Fontana L.
    In Vivo; 2004 Feb 15; 18(2):229-35. PubMed ID: 15113051
    [Abstract] [Full Text] [Related]

  • 7. Isolated pulmonary hypertension in systemic sclerosis with diffuse cutaneous involvement: association with serum anti-U3RNP antibody.
    Sacks DG, Okano Y, Steen VD, Curtiss E, Shapiro LS, Medsger TA.
    J Rheumatol; 1996 Apr 15; 23(4):639-42. PubMed ID: 8730118
    [Abstract] [Full Text] [Related]

  • 8. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
    Jacobsen S, Ullman S, Shen GQ, Wiik A, Halberg P.
    J Rheumatol; 2001 Nov 15; 28(11):2454-9. PubMed ID: 11708418
    [Abstract] [Full Text] [Related]

  • 9. [Lung impairment in systemic sclerosis].
    Knoop H, Arinir U, Kreuter A, Walther JW, Schultze-Werninghaus G, Rohde G.
    Pneumologie; 2009 Sep 15; 63(9):497-507. PubMed ID: 19708006
    [Abstract] [Full Text] [Related]

  • 10. Renal function is mostly preserved in patients with systemic sclerosis.
    Scheja A, Bartosik I, Wuttge DM, Hesselstrand R.
    Scand J Rheumatol; 2009 Sep 15; 38(4):295-8. PubMed ID: 19214870
    [Abstract] [Full Text] [Related]

  • 11. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database.
    Walker UA, Tyndall A, Czirják L, Denton C, Farge-Bancel D, Kowal-Bielecka O, Müller-Ladner U, Bocelli-Tyndall C, Matucci-Cerinic M.
    Ann Rheum Dis; 2007 Jun 15; 66(6):754-63. PubMed ID: 17234652
    [Abstract] [Full Text] [Related]

  • 12. Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibody.
    Perera A, Fertig N, Lucas M, Rodriguez-Reyna TS, Hu P, Steen VD, Medsger TA.
    Arthritis Rheum; 2007 Aug 15; 56(8):2740-6. PubMed ID: 17665460
    [Abstract] [Full Text] [Related]

  • 13. The -670G>A polymorphism in the FAS gene promoter region influences the susceptibility to systemic sclerosis.
    Liakouli V, Manetti M, Pacini A, Tolusso B, Fatini C, Toscano A, Cipriani P, Guiducci S, Bazzichi L, Codullo V, Ruocco L, Dell'orso L, Carubbi F, Marrelli A, Abbate R, Bombardieri S, Ferraccioli G, Montecucco C, Valentini G, Matucci-Cerinic M, Ibba-Manneschi L, Giacomelli R.
    Ann Rheum Dis; 2009 Apr 15; 68(4):584-90. PubMed ID: 18445624
    [Abstract] [Full Text] [Related]

  • 14. Survival, causes of death, and risk factors associated with mortality in Spanish systemic sclerosis patients: results from a single university hospital.
    Joven BE, Almodovar R, Carmona L, Carreira PE.
    Semin Arthritis Rheum; 2010 Feb 15; 39(4):285-93. PubMed ID: 19782387
    [Abstract] [Full Text] [Related]

  • 15. Severe organ involvement in systemic sclerosis with diffuse scleroderma.
    Steen VD, Medsger TA.
    Arthritis Rheum; 2000 Nov 15; 43(11):2437-44. PubMed ID: 11083266
    [Abstract] [Full Text] [Related]

  • 16. [Strategy for early diagnosis of lung involvement in systemic scleroderma].
    Diot E, Valat C, Boissinot E, Giraudeau B, Asquier E, Guilmot JL, Lemarié E, Diot P.
    Rev Mal Respir; 2000 Dec 15; 17(6):1073-80. PubMed ID: 11217502
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Can CCL2 serum levels be used in risk stratification or to monitor treatment response in systemic sclerosis?
    Carulli MT, Handler C, Coghlan JG, Black CM, Denton CP.
    Ann Rheum Dis; 2008 Jan 15; 67(1):105-9. PubMed ID: 17604287
    [Abstract] [Full Text] [Related]

  • 19. Systemic sclerosis sine scleroderma: a multicenter study of 1417 subjects.
    Diab S, Dostrovsky N, Hudson M, Tatibouet S, Fritzler MJ, Baron M, Khalidi N, Canadian Scleroderma Research Group.
    J Rheumatol; 2014 Nov 15; 41(11):2179-85. PubMed ID: 25274885
    [Abstract] [Full Text] [Related]

  • 20. Skin sclerosis is only of limited value to identify SSc patients with severe manifestations--an analysis of a distinct patient subgroup of the German Systemic Sclerosis Network (DNSS) Register.
    Hanitsch LG, Burmester GR, Witt C, Hunzelmann N, Genth E, Krieg T, Lehmacher W, Melchers I, Meurer M, Müller-Ladner U, Schulze-Lohoff E, Becker M, Sunderkoetter C, DNSS centers, Riemekasten G.
    Rheumatology (Oxford); 2009 Jan 15; 48(1):70-3. PubMed ID: 19056798
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.